Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients

被引:0
|
作者
Fajami, Zahra [1 ]
Akbarin, Mohammad Mehdi [2 ]
Rafatpanah, Houshang [1 ]
Ramezani, Samaneh [1 ]
Rahimi, Hossein [3 ]
Rezaee, Seyed Abdolrahim [1 ,4 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Modern Sci & Technol, Mashhad, Iran
[2] Mashhad Univ Med Sci, Fac Med, Inflammat & Inflammatory Dis Res Ctr, Mashhad, Iran
[3] Mashhad Univ Med Sci, Ghaem Hosp, Fac Med, Dept Hematol, Mashhad, Iran
[4] Mashhad Univ Med Sci, Fac Med, Med Sch, Dept Modern Sci & Technol, Azadi Sq, Mashhad 9177948959, Iran
关键词
HTLV-1; ATLL; Tax; Bcl-xL; apoptosis; HBZ; HTLV-I INFECTION; VIRUS TYPE-1 TAX; APOPTOSIS; ATL; INDUCTION; PATHWAY; ACTIVATION; PROTEINS; SURVIVAL; THERAPY;
D O I
10.1089/aid.2023.0025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adult T cell leukemia/lymphoma is a malignancy with a poor prognosis caused by human T lymphocyte virus type 1 (HTLV-1) infection. Tax and HBZ are two major viral proteins that may be involved in oncogenesis by disrupting apoptosis. Because Bcl-xL plays an integral role in the anti-apoptotic pathway, this study examines the interaction between host apoptosis and oncoproteins. We investigated 37 HTLV-1-infected individuals, including 18 asymptomatic and 19 adult T cell leukemia/lymphoma (ATLL) subjects. mRNA was extracted and converted to cDNA from peripheral blood mononuclear cells, and then gene expression was determined using TaqMan q-PCR. Moreover, the HTLV-1 proviral load (PVL) was also measured using a commercial absolute quantification kit (Novin Gene, Iran). Data analysis revealed that the mean of TAX, HBZ, and PVL was significantly higher among the study groups (ATLL and carrier groups p = .003, p = .000, and p = .002 respectively). There was no statistical difference in Bcl-xL gene expression between the study groups (p = .323). It is proposed that this anti-apoptotic pathway may not be directly involved in the development of ATLL lymphoma. Bcl-xL, TAX, HBZ gene expression, and PVL can be utilized as prognostic markers.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [21] BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia
    Gonzalez, Mariana S.
    De Brasi, Carlos D.
    Bianchini, Michele
    Gargallo, Patricia
    Moiraghi, Beatriz
    Bengio, Raquel
    Larripa, Irene B.
    BLOOD CELLS MOLECULES AND DISEASES, 2010, 45 (03) : 192 - 196
  • [22] Prognostic significance of Bcl-xL gene expression in human colorectal cancer
    Yang, Jin-Song
    Wang, Zhao-Xia
    Lv, Cheng-Yu
    Liang, Xiao-Di
    Sun, Ming
    Guo, Yuan-Yuan
    De, Wei
    ACTA HISTOCHEMICA, 2011, 113 (08) : 810 - 814
  • [23] Targeting BCL-xL overcomes resistance to brentuximab vedotin in CD30+T-cell lymphoma
    Schmidt, C., V
    Ackermann, P. N. F.
    Ries, L.
    Schmidt, N.
    Ksionsko, N.
    Shumilov, E.
    Wulf, G. G.
    Koch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 191 - 191
  • [24] THE EXPRESSION AND SIGNIFICANCE OF TLR-4 AND BCL-XL IN CHILDREN WITH ACUTE LEUKEMIA
    Miao, L. I. U.
    Qingzhao, S. H. I.
    Rong, T. A. N. G.
    Yi, J.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S269 - S269
  • [25] Transgenic expression of bcl-xL in T cells enhances susceptibility to EAE
    Chitnis, T
    Abdallah, KA
    Issazadeh, S
    Anil, C
    Wells, AD
    Turka, LA
    Sayegh, MH
    Khoury, SJ
    NEUROLOGY, 1999, 52 (06) : A464 - A465
  • [26] Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas
    Gobé, G
    Rubin, M
    Williams, G
    Sawczuk, I
    Buttyan, R
    CANCER INVESTIGATION, 2002, 20 (03) : 324 - 332
  • [27] Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck
    Pena, JC
    Thompson, CB
    Recant, W
    Vokes, EE
    Rudin, CM
    CANCER, 1999, 85 (01) : 164 - 170
  • [29] Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia
    Zhang, Meili
    Griner, Lesley A. Mathews
    Ju, Wei
    Duveau, Damien Y.
    Guha, Rajarshi
    Petrus, Michael N.
    Wen, Bernard
    Maeda, Michiyuki
    Shinn, Paul
    Ferrer, Marc
    Conlon, Kevin D.
    Bamford, Richard N.
    O'Shea, John J.
    Thomas, Craig J.
    Waldmann, Thomas A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (40) : 12480 - 12485
  • [30] Bax and Bcl-XL expression are not related to prognosis in patients with advanced esophageal squamous cell carcinoma
    Natsugoe, S
    Matsumoto, M
    Okumura, H
    Nakashima, S
    Sakamoto, F
    Sakita, H
    Baba, M
    Takao, S
    Aikou, T
    CANCER LETTERS, 2001, 174 (01) : 91 - 97